Literature DB >> 7529962

Is congenital bilateral absence of vas deferens a primary form of cystic fibrosis? Analyses of the CFTR gene in 67 patients.

B Mercier1, C Verlingue, W Lissens, S J Silber, G Novelli, M Bonduelle, M P Audrézet, C Férec.   

Abstract

Congenital bilateral absence of the vas deferens (CBAVD) is an important cause of sterility in men. Although the genetic basis of this condition is still unclear, it has been shown recently that some of these patients carry mutations in their cystic fibrosis transmembrane conductance regulator (CFTR) genes. To extend this observation, we have analyzed the entire coding sequence of the CFTR gene in a cohort of 67 men with CBAVD, who are otherwise healthy. We have identified four novel missense mutations (A800G, G149R, R258G, and E193K). We have shown that 42% of subjects were carriers of one CFTR allele and that 24% are compound heterozygous for CFTR alleles. Thus, we have been unable to identify 76% of these patients as carrying two CFTR mutations. Furthermore, we have described the segregation of CFTR haplotypes in the family of one CBAVD male; in this family are two male siblings, with identical CFTR loci but displaying different phenotypes, one of them being fertile and the other sterile. The data presented in this family, indicating a discordance between the CBAVD phenotype and a marked carrier (delta F508) chromosome, support the involvement of another gene(s), in the etiology of CBAVD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7529962      PMCID: PMC1801292     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  34 in total

1.  Identification of 12 novel mutations in the CFTR gene.

Authors:  M P Audrézet; B Mercier; H Guillermit; I Quéré; C Verlingue; G Rault; C Férec
Journal:  Hum Mol Genet       Date:  1993-01       Impact factor: 6.150

2.  Identification of eight novel mutations in a collaborative analysis of a part of the second transmembrane domain of the CFTR gene.

Authors:  B Mercier; W Lissens; G Novelli; L Kalaydjieva; M De Arce; N Kapranov; N C Klain; G Lenoir; P Chauveau; C Lenaerts
Journal:  Genomics       Date:  1993-04       Impact factor: 5.736

3.  Computational simulation of DNA melting and its application to denaturing gradient gel electrophoresis.

Authors:  L S Lerman; K Silverstein
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  Genital abnormalities in male patients with cystic fibrosis.

Authors:  D S Holsclaw; A D Perlmutter; H Jockin; H Shwachman
Journal:  J Urol       Date:  1971-10       Impact factor: 7.450

5.  [Paternity in a patient with mucoviscidosis. Study of genital functions and filiation].

Authors:  J Feigelson; Y Pecau; H Shwachman
Journal:  Arch Fr Pediatr       Date:  1969-10

6.  Detection of 98.5% of the mutations in 200 Belgian cystic fibrosis alleles by reverse dot-blot and sequencing of the complete coding region and exon/intron junctions of the CFTR gene.

Authors:  H Cuppens; P Marynen; C De Boeck; J J Cassiman
Journal:  Genomics       Date:  1993-12       Impact factor: 5.736

7.  Analysis of the 27 exons and flanking regions of the cystic fibrosis gene: 40 different mutations account for 91.2% of the mutant alleles in southern France.

Authors:  M Claustres; M Laussel; M Desgeorges; M Giansily; J F Culard; G Razakatsara; J Demaille
Journal:  Hum Mol Genet       Date:  1993-08       Impact factor: 6.150

8.  Detection of over 98% cystic fibrosis mutations in a Celtic population.

Authors:  C Férec; M P Audrezet; B Mercier; H Guillermit; P Moullier; I Quere; C Verlingue
Journal:  Nat Genet       Date:  1992-06       Impact factor: 38.330

9.  A mutation in CFTR produces different phenotypes depending on chromosomal background.

Authors:  S Kiesewetter; M Macek; C Davis; S M Curristin; C S Chu; C Graham; A E Shrimpton; S M Cashman; L C Tsui; J Mickle
Journal:  Nat Genet       Date:  1993-11       Impact factor: 38.330

10.  Nasal epithelial ion transport and genetic analysis of infertile men with congenital bilateral absence of the vas deferens.

Authors:  L R Osborne; M Lynch; P G Middleton; E W Alton; D M Geddes; J P Pryor; M E Hodson; G K Santis
Journal:  Hum Mol Genet       Date:  1993-10       Impact factor: 6.150

View more
  22 in total

Review 1.  Genetically determined male infertility and assisted reproduction techniques.

Authors:  T Hargreave
Journal:  J Endocrinol Invest       Date:  2000-11       Impact factor: 4.256

2.  Analysis of most common CFTR mutations in patients affected by nasal polyps.

Authors:  Marzena Kostuch; Janusz Klatka; Andrzej Semczuk; Jacek Wojcierowski; Lucas Kulczycki; Jan Oleszczuk
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-06-17       Impact factor: 2.503

3.  The Réunion paradox and the digenic model.

Authors:  J S Beckmann
Journal:  Am J Hum Genet       Date:  1996-12       Impact factor: 11.025

4.  Human epithelial cystic fibrosis transmembrane conductance regulator without exon 5 maintains partial chloride channel function in intracellular membranes.

Authors:  J Xie; M L Drumm; J Zhao; J Ma; P B Davis
Journal:  Biophys J       Date:  1996-12       Impact factor: 4.033

5.  Expression and function of human MRP1 (ABCC1) is dependent on amino acids in cytoplasmic loop 5 and its interface with nucleotide binding domain 2.

Authors:  Surtaj H Iram; Susan P C Cole
Journal:  J Biol Chem       Date:  2010-12-20       Impact factor: 5.157

Review 6.  Congenital bilateral absence of the vas deferens as an atypical form of cystic fibrosis: reproductive implications and genetic counseling.

Authors:  D A S de Souza; F R Faucz; L Pereira-Ferrari; V S Sotomaior; S Raskin
Journal:  Andrology       Date:  2017-12-07       Impact factor: 3.842

7.  A neutral variant involved in a complex CFTR allele contributes to a severe cystic fibrosis phenotype.

Authors:  Jérôme Clain; Jacqueline Lehmann-Che; Emmanuelle Girodon; Joanna Lipecka; Aleksander Edelman; Michel Goossens; Pascale Fanen
Journal:  Hum Genet       Date:  2005-03-03       Impact factor: 4.132

Review 8.  Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice.

Authors:  C Castellani; H Cuppens; M Macek; J J Cassiman; E Kerem; P Durie; E Tullis; B M Assael; C Bombieri; A Brown; T Casals; M Claustres; G R Cutting; E Dequeker; J Dodge; I Doull; P Farrell; C Ferec; E Girodon; M Johannesson; B Kerem; M Knowles; A Munck; P F Pignatti; D Radojkovic; P Rizzotti; M Schwarz; M Stuhrmann; M Tzetis; J Zielenski; J S Elborn
Journal:  J Cyst Fibros       Date:  2008-05       Impact factor: 5.482

9.  Counseling and screening for cystic fibrosis in patients with congenital bilateral absence of the vas deferens: Patient perceptions.

Authors:  J L Fitzpatrick; E M Hutton; R Babul; C S Cytrynbaum; J E Sutherland; C T Shuman
Journal:  J Genet Couns       Date:  1996-03       Impact factor: 2.537

10.  Assessing the Disease-Liability of Mutations in CFTR.

Authors:  Claude Ferec; Garry R Cutting
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.